Det primære mål for virkning var andelen af børn, der udviklede beskyttende niveauer af antistoffer mod hepatitis A og hepatitis B.
The main measure of effectiveness was the proportion of the children who had developed protective levels of antibodies to hepatitis A and hepatitis B.